Human Organoids Market Regional Analysis:
Asia Pacific Market Insights
The Asia Pacific human organoids market is projected to hold the largest market share by the end of 2035. The growth of the market can be attributed majorly to the rising need for organ transplantation and donation. According to the National Institutes of Health in 2022, 453.3 million people were suffering from chronic kidney disorders across southern, eastern and southern eastern regions of Asia. Furthermore, rising cases of infectious disease in the region are expected to boost the market growth.
In India, the market is expected to register rapid growth during the forecast period owing to rising incidence of cancer, government initiatives to promote human organoids, and supportive regulations for the development and commercialization of advanced human organoid products. Moreover, rising investments in gene mutation and cancer research and rapid adoption of advanced technologies are expected to fuel market growth in India going ahead.
North America Market Insights
The human organoids market in North America is projected to offer lucrative growth opportunities due to rising investment in research and development activities and the presence of robust healthcare and research facilities. The National Science Foundation stated that in the U.S., investment in R&D reached USD 886 billion in 2022. Also, there is commercialization of organoid models and stem cell research. In Canada, researchers are using cerebral organoids to treat neurological diseases. In March 2024, Sinai Health infused USD 10 million in funding to fuel the creation of lab-grown organoids for drug discovery.
